Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7463095 | 0.69 | KDM1A (0.34) | KDM1A | |
| SCHEMBL6396884 | 0.66 | — | — | |
| SCHEMBL17258186 | 0.66 | — | — | |
| SCHEMBL15657725 | 0.62 | ROCK2 (0.40) | — | |
| SCHEMBL12902859 | 0.62 | ROCK2 (0.32) | — | |
| SCHEMBL23914201 | 0.62 | — | — | |
| SCHEMBL6682662 | 0.62 | KDM1A (0.48) | HSD11B1KDM1ANPC1EPHX1RAB9A | |
| SCHEMBL235344 | 0.62 | KDM1A (0.48) | HSD11B1KDM1ANPC1EPHX1RAB9A | |
| SCHEMBL123151 | 0.62 | KDM1A (0.48) | HSD11B1KDM1ANPC1EPHX1RAB9A | |
| SCHEMBL20552191 | 0.62 | KDM1A (0.48) | HSD11B1KDM1ANPC1EPHX1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101031595-A | One-component cationic palladium pre-initiator for the latent polymerization of cycloolefins | PROMERUS LLC (US) | 2007-09-05 | — | — | CN | claimed |
| EP-1680218-A2 | SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS | Promerus, LLC (US) | 2006-07-19 | — | — | EP | claimed |
| WO-2005042147-A2 | SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS | PROMERUS, LLC (US) | 2005-05-12 | — | — | WO | claimed |
| CN-101031595-A | One-component cationic palladium pre-initiator for the latent polymerization of cycloolefins | PROMERUS LLC (US) | 2007-09-05 | — | — | CN | disclosed |
| EP-1680218-A2 | SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS | Promerus, LLC (US) | 2006-07-19 | — | — | EP | disclosed |
| US-20050187398-A1 | Single component cationic palladium proinitiators for the latent polymerization of cycloolefins | PROMERUS, LLC | 2005-08-25 | — | — | US | disclosed |
| WO-2005042147-A2 | SINGLE COMPONENT CATIONIC PALLADIUM PROINITIATORS FOR THE LATENT POLYMERIZATION OF CYCLOOLEFINS | PROMERUS, LLC (US) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187398-A1 | Single component cationic palladium proinitiators for the latent polymerization of cycloolefins | LRRK2, LBR, SNCA | HSD11B1 4294/4885KDM1A 2422/4885NPC1 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.